Brief: China Regenerative Medicine International Announces Termination Of Open Offer
19/02/2020 01:37
Feb 19 (Reuters) - China Regenerative Medicine International
Ltd 8158.HK :
* NOTIFIED BY SBI CHINA CAPITAL FINANCIAL SERVICES IT
DECIDED TO
TERMINATE AGREEMENT DATED NOV 27, 2019
Source text for Eikon: urn:newsml:reuters.com:*:nHKSdfLsb
Further company coverage: 8158.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Regenerative Medicine International
See all newsBrief: China Regenerative Medicine International Expects FY Profit To Increase At Least 28%
Brief: China Regenerative Medicine International Says Yan Shibin Will Be Appointed As CFO
Brief: China Regenerative Medicine International Posts H1 Revenue Of HKD59.78 Mln
Brief: China Regenerative Medicine International Posts FY Loss Attributable HK$107.7 Mln
Brief: China Regenerative Medicine International Says Subscription Of Increased Registered Capital